sitemap.xml - Search
About 10,600 results
Open links in new tab
    Kizdar net | Kizdar net | Кыздар Нет
  1. Newron Pharmaceuticals SpA v The Comptroller General of Patents

    Feb 15, 2024 · United Kingdom - Date of Judgment: February 15, 2024 - Court of Appeal (EWCA) - Appellate Instance - Judicial …

  2. Court of Appeal upholds UKIPO rejection of SPC for Parkinson's ...

    Feb 22, 2024 · The UK Court of Appeal has dismissed an appeal brought by Newron Pharmaceuticals concerning an SPC for a drug …

  3. Newron Pharmaceuticals SpA v The Comptroller General of Patents ...

    The Court upheld the Hearing Officer and the High Court's conclusion that the marketing authorisation authorised safinamide as the …

  4. Newron: Patentstreit um Xadago vor Gericht - ad-hoc-news

    Jul 1, 2026 · Das Münchner Landgericht verhandelt heute über Einwände von Generikaherstellern gegen den Patentschutz von …

  5. Dutch court surprises with swift decision on Newron’s SPC for Xadago

    Nov 18, 2025 · At a hearing at the District Court The Hague, Italian pharmaceutical company Newron defended its SPC for …

  6. Newron can't play fast and loose: UK Patents Court restricts…

    Aug 1, 2023 · Newron appealed that decision to the UK Patents Court, arguing that the term “product” may have a different meaning …

  7. Newron Pharmaceuticals SPA (appellant) v The Comptroller-General …

    Jan 24, 2024 · This is an appeal against the decision of Recorder Douglas Campbell KC dated 23 June 2023, that dismissed the …

  8. Newron Pharmaceutical SpA v Comptroller General of Patents, …

    Jun 16, 2023 · In the Court of Appeal, Newron Pharmaceuticals' appeal against the refusal of a supplementary protection certificate …

  9. Newron can't play fast and loose: UK Patents Court restricts

    Aug 1, 2023 · Newron appealed that decision to the UK Patents Court, arguing that the term “product” may have a different meaning …

  10. Newron Pharmaceuticals SPA v The Comptroller General of Patents ...

    Feb 15, 2024 · Get free access to the complete judgment in Newron Pharmaceuticals SPA v The Comptroller General of Patents, …